Report

genital herpes treatment market

Genital Herpes Treatment Market by Type of Drugs (Acyclovir, Famciclovir, Valacyclovir, and Others), Distribution channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies), Route of Administration (Oral and Topical), and Geography – Global Forecast up to 2027

pages Pages: 98
tables Tables: 94
charts Charts: 64
country Regions/Countries: 4 / 10
compaines Companies: 10
enqhours Enquiry Hours: 10
  • Get Free 10% Customization in this Report

COVID - 19

Covid impact updated reports at special price

Genital herpes is classified as a sexually transmitted disease or infection (STI) which is caused due to herpes simplex virus. Genital herpes is diagnosed through painful blisters on and areas surrounding genitals of both men and women affecting mucus membrane which exist in the body. Genital herpes is most usual among women when compared with men. Genital herpes is a chronic condition, and presently no permanent cure has been discovered. However, medication is available to control triggered symptoms of the disease. Escalating demand for effective therapeutic options for the treatment of these infections is projected to accelerate the genital herpes treatment market during the forecasting period. In order to address the urgent requirement of better treatment for sexually transmitted infections and to fight the rapid development of antiviral-resistant species, governments around the world have taken initiatives that would support the growth of the genital herpes treatment market. Apart from that, the high expenses incurred in the treatment of genital herpes treatment are likely to hamper the market growth. As a result, the genital herpes treatment market is anticipated to grow at the rate of 4.1% CAGR by 2027. 

Research Methodology:

The genital herpes treatment market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an important part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Genital Herpes Treatment Market

Genital Herpes Treatment Market based on Type of Drugs

  • Acyclovir
  • Famciclovir
  • Valacyclovir
  • Others

Genital Herpes Treatment Market based on Distribution channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug stores
  • Online Pharmacies

Genital Herpes Treatment Market based on Route of Administration

  • Oral
  • Topical

Genital Herpes Treatment Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

On the basis of types of drugs, the genital herpes treatment market is majorly divided into Acyclovir, Famciclovir, Valacyclovir, and Others. The acyclovir drug type is projected to have a significant share in the market. The acyclovir drugs are considered very effective in suppressing the frequency and quantity of the genital herpes simplex virus. Acyclovir decreases the pain and speeds the healing of sores or blisters in people who had first-time or repeat outbreaks of genital herpes. It works by preventing the spread of the herpes virus in the body. Thus, the above-mentioned advantages of the acyclovir drug are boosting segment growth.

Further on the basis of distribution channel, the genital herpes treatment market has been classified into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Among all of the distribution channels, the online pharmacies segment is projected to acquire a maximum share in the market. This is due to the increasing number of online pharmacy websites for the drugs which offer various discounts and growing customer preference for online pharmacies for drugs pushing for the segment growth.  

On the basis of route of administration, the genital herpes treatment market is bifurcated into oral and topical. The oral administration route segment has a major share in the market. This is due to customer preference for oral treatment, facilitated by application ease and effectiveness.

As per the market by geography, the market is categorized into North America, Europe, Asia Pacific, and the rest of the world. North America region made a substantial contribution in the market. This is majorly due to the increasing patients’ awareness, better infrastructure, and relatively higher cost of treatment in the region.

The rising prevalence of sexually transmitted diseases, changing socio-cultural openness, and growing awareness are projected to boost the demand for genital herpes treatment over the forecast period. For instance, as per the center for disease control and prevention, approximately 50 million people affected with genital herpes in the U.S. Factors such as increasing diagnosis rate in developing countries and increasing clinical trial of vaccines for genital herpes has also propelled the growth of the global genital herpes treatment market during the forecast period.

The major leading companies of the genital herpes treatment market are Novopharm Ltd., Teva Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Genocea Biosciences, Mylan Pharmaceuticals Inc., Apotheca Inc., GlaxoSmithKline, Sandoz Inc., Novartis AG, Hospira Inc.

Genital herpes is a disease, which does not have a complete treatment but the medications are available which are playing a crucial part in suppressing the frequency and quantity of genital herpes among people. Moreover, the awareness has increased among people regarding genital herpes has increased the market demand.

  • The study offers a thorough analysis of the genital herpes treatment market size along with the present trends and forthcoming estimations to describe the impending investment pockets.
  • It also offers the genital herpes treatment market analysis over the forecast period, which is projected to allow the shareholders to benefit from the opportunities in the market.
  • Comprehensive insights of the four major regions are depicted to determine the potential opportunities.
  • The profiles and dynamic strategies of the major competitors are completely analyzed to understand the competitive outlook and global genital herpes treatment market growth.
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Overview
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    4. DRO - Impact Analysis
  5. Type of Drugs: Market Size & Analysis
    1. Overview
    2. Acyclovir
    3. Famciclovir
    4. Valacyclovir
    5. Others
  6. Distribution channels: Market Size & Analysis
    1. Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Drug stores
    5. Online Pharmacies
  7. Route of Administration: Market Size & Analysis
    1. Overview
    2. Oral
    3. Topical
  8. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  9. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  10. Vendor Profiles
    1. Novopharm Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    2. Teva Pharmaceuticals Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    3. Dr. Reddy’s Laboratories Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    4. Genocea Biosciences
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    5. Mylan Pharmaceuticals Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    6. Apotheca Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    7. GlaxoSmithKline
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    8. Sandoz Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    9. Novartis AG
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    10. Hospira Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
  11. Analyst Opinion
  12. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

TABLE 1.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 2.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 3.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR FAMCICLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 4.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR VALACYCLOVIR, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 5.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 6.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 7.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 8.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 9.           GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR DRUG STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 10.         GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ONLINE PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 11.         GLOBAL GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 12.         GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR ORAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 13.         GLOBAL GENITAL HERPES TREATMENT MARKET VALUE FOR TOPICAL, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 14.         NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 15.         NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 16.         NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 17.         NORTH AMERICA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 18.         U.S GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 19.         U.S GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 20.         U.S GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 21.         CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 22.         CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 23.         CANADA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 24.         EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 25.         EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 26.         EUROPE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 27.         EUROPE GENITAL HERPES TREATMENT MARKET VALUE, ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 28.         GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 29.         GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 30.         GERMANY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 31.         U.K GENITAL HERPES TREATMENT  MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 32.         U.K GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 33.         U.K GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 34.         FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 35.         FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 36.         FRANCE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 37.         ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 38.         ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 39.         ITALY GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 40.         SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 41.         SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 42.         SPAIN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 43.         ROE GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 44.         ROE GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 45.         ROE GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 46.         ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 47.         ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 48.         ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 49.         ASIA PACIFIC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 50.         CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 51.         CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 52.         CHINA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 53.         INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 54.         INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 55.         INDIA GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 56.         JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 57.         JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 58.         JAPAN GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 59.         REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 60.         REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 61.         REST OF APAC GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 62.         REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY TYPE OF DRUGS, 2021-2027 (USD BILLION)

TABLE 63.         REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNELS, 2021-2027 (USD BILLION)

TABLE 64.         REST OF WORLD GENITAL HERPES TREATMENT MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2021-2027 (USD BILLION)

TABLE 65.         NOVOPHARM LTD.: FINANCIALS          

TABLE 66.         NOVOPHARM LTD.: PRODUCTS & SERVICES     

TABLE 67.         NOVOPHARM LTD.: RECENT DEVELOPMENTS   

TABLE 68.         TEVA PHARMACEUTICALS INC.: FINANCIALS    

TABLE 69.         TEVA PHARMACEUTICALS INC.: PRODUCTS & SERVICES          

TABLE 70.         TEVA PHARMACEUTICALS INC.: RECENT DEVELOPMENTS        

TABLE 71.         DR. REDDY’S LABORATORIES LTD: FINANCIALS           

TABLE 72.         DR. REDDY’S LABORATORIES LTD: PRODUCTS & SERVICES     

TABLE 73.         DR. REDDY’S LABORATORIES LTD: RECENT DEVELOPMENTS   

TABLE 74.         GENOCEA BIOSCIENCES: FINANCIALS 

TABLE 75.         GENOCEA BIOSCIENCES: PRODUCTS & SERVICES       

TABLE 76.         GENOCEA BIOSCIENCES: RECENT DEVELOPMENTS      

TABLE 77.         MYLAN PHARMACEUTICALS INC: FINANCIALS  

TABLE 78.         MYLAN PHARMACEUTICALS INC: PRODUCTS & SERVICES        

TABLE 79.         MYLAN PHARMACEUTICALS INC: RECENT DEVELOPMENTS       

TABLE 80.         APOTHECA INC: FINANCIALS   

TABLE 81.         APOTHECA INC: PRODUCTS & SERVICES         

TABLE 82.         APOTHECA INC: RECENT DEVELOPMENTS        

TABLE 83.         GLAXOSMITHKLINE: FINANCIALS         

TABLE 84.         GLAXOSMITHKLINE: PRODUCTS & SERVICES   

TABLE 85.         GLAXOSMITHKLINE: RECENT DEVELOPMENTS 

TABLE 86.         SANDOZ INC: FINANCIALS      

TABLE 87.         SANDOZ INC: PRODUCTS & SERVICES 

TABLE 88.         SANDOZ INC: RECENT DEVELOPMENTS

TABLE 89.         NOVARTIS AG: FINANCIALS     

TABLE 90.         NOVARTIS AG: PRODUCTS & SERVICES           

TABLE 91.         NOVARTIS AG: RECENT DEVELOPMENTS          

TABLE 92.         HOSPIRA INC: FINANCIALS      

TABLE 93.         HOSPIRA INC: PRODUCTS & SERVICES

TABLE 94.         HOSPIRA INC: RECENT DEVELOPMENTS

Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting
Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

outicon

Genital Herpes Treatment Market by Type of Drugs (Acyclovir, Famciclovir, Valacyclovir, and Others), Distribution channels (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies), Route of Administration (Oral and Topical), and Geography – Global Forecast up to 2027
Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports